Live symbol workspace

MRK market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $120.89

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$114.85

Resistance

$126.93

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$120.89

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

31%

▲ 0.9 pts vs previous week

Avg confidence across 23 calls in the last 7 days

What sources say

Bullish 1 article

JPMorgan says this S&P 500 sector "offers a rare combination of durable growth"

Neutral 1 article

Dow Futures Slip, S&P 500, Nasdaq Futures Climb Ahead Of Key Retail Earnings, Fed Minutes: NLST, AVGO, LUNR, MRK Stocks In Focus

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

MRK News Intelligence (12 articles)

AI-curated news influencing MRK price, sentiment, and trend

Explore All MRK News with AI Analysis

Economy

4 days, 1 hour ago

Dow Futures Slip, S&P 500, Nasdaq Futures Climb Ahead Of Key Retail Earnings, Fed Minutes: NLST, AVGO, LUNR, MRK Stocks In Focus

Dow futures were down 0.09%, while the S&P 500 futures climbed 0.09% and the Nasdaq-100 futures were up 0.25% at …

Impact on MRK: The mixed futures performance suggests a cautious market approach ahead of key …

Dow futures slipped 0.09% while S&P 500 and Nasdaq-100 futures rose 0.09% and 0.25% respectively … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

3 weeks, 2 days ago

JPMorgan says this S&P 500 sector "offers a rare combination of durable growth"

Investing.com -- JPMorgan reiterated a favorable view on the healthcare sector in a note Tuesday, calling the risk/reward attractive after …

Impact on MRK: The JPMorgan note may lead to a positive price reflection in healthcare …

JPMorgan has reiterated its favorable view on the S&P 500 healthcare sector, citing an attractive … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

1 month, 1 week ago

Nasdaq, S&P 500, Dow Futures Fall After Trump Directs Strikes ‘To Hold Iranian Forces Accountable’: NVDA, SLS, MRK, SKHYV, QS Stocks In Focus

U.S. Central Command said that American forces had begun launching further strikes against Iran to thwart their ability “to attack …

Impact on MRK: The escalation of tensions between the US and Iran is likely to …

US launches strikes against Iran, sparking concerns over geopolitical tensions and potential market volatility, with … High (80%)

View full analysis →

Yahoo Finance 80% confidence

Economy

1 month, 1 week ago

Merck (MRK) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Merck (MRK) stood at $123.54, denoting a -1.22% move from the preceding …

Impact on MRK: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

1 month, 2 weeks ago

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Compare portfolio concentration, risk profiles, and long-term growth as these two pharma ETFs take different approaches to capturing sector opportunity.

Impact on MRK: The comparison may lead to a rotation of capital between PPH and …

The article compares VanEck's PPH and Invesco's PJP pharmaceutical ETFs, focusing on portfolio concentration, risk … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

2 months ago

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

Pfizer’s recent drug approvals give the company something to build on, with shareholders looking for evidence that cost cuts and …

Impact on MRK: Pfizer's stock price (PFE) may decline due to the CFO transition, potentially …

Pfizer's CFO transition has sparked concerns about the company's ability to meet its 2026 earnings … High (70%)

View full analysis →

Yahoo Finance 70% confidence